Copyright
©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 706-729
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.706
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.706
Figure 5 Strategies for treating type 2 diabetes mellitus and concurrent osteoporosis.
CKD-MBD: Chronic kidney disease–mineral and bone disorder; DPP-4i: Dipeptidyl-peptidase 4 inhibitor; GLP-1: Glucagon-like peptide-1; T2DM: Type 2 diabetes mellitus.
- Citation: Palui R, Pramanik S, Mondal S, Ray S. Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus. World J Diabetes 2021; 12(6): 706-729
- URL: https://www.wjgnet.com/1948-9358/full/v12/i6/706.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i6.706